Tribio Anti-Human BCMA & CD3E Bispecific Antibody (TBS10424)
$479.00 – $1,919.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10424-100 | Yes | 100 UG | $479.00 | |||
| TBS10424-1 | Yes | 1 MG | $1,919.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio Tribio BCMA & CD3E Bispecific Antibody is a modified antibody that binds BCMA on plasma cells and CD3E on T cells at the same time. It brings T cells into close contact with BCMA-positive cells, activating T cells to kill these target cells. It is widely used in cancer immunotherapy research, especially for studying multiple myeloma and other plasma cell malignancies.
Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species reactivity: Human
Host species: Human
Target: Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD269, B-cell maturation protein, BCMA, BCM, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Isotype: IgG
Accession/UniProt: Q02223 & P07766
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio Anti-Human BCMA & CD3E Bispecific Antibody (TBS10424)”
You must be logged in to post a review.
Reviews
There are no reviews yet.